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finalization was reduced by respectively 0.7 and 0.9 days for 
the conventional and ConWIP (no patient appointment) 
workflows. The implementation of RT-Flow reduced greatly 
the delays of MDs generally having prior long delays. 
 
Conclusion: Implementation of the workflow optimization 
software RT-Flow has reduced the delays and improved 
productivity, whilst giving users better control over work and 
better prioritization for patients. Both conventional workflow 
and ConWip workflows but also personnel stress levels have 
proven to be improved. Future work will focus on population 
TCP optimization and booking curves. 
[1] Crop, F., Lacornerie, T., Mirabel, X. & Lartigau, E. 
Workflow optimization for robotic stereotactic radiotherapy 
treatments: Application of Constant Work In Progress 
workflow. Oper. Res. Heal. Care 6, 18–22 (2015). 
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Purpose or Objective: There is no threshold limit for 
radiation induced cardiac toxicity, making it especially 
relevant for cardiac sparing radiation delivery in adjuvant 
breast radiotherapy. Deep inspiratory breath hold (DIBH) 
technique is one method for reducing the heart dose, 
however, it is resource intensive. This study analyses the cost 
of cardiac sparing using DIBH and its associated benefits. 
 
Material and Methods: DIBH technique using Varian RPM, was 
used to deliver radiotherapy for 50 consecutive patients of 
left sided breast cancer. The time required in minutes and 
the number of personnel involved during each step of the 
planning and the treatment (40Gy in 15 fractions) were 
recorded. Weighted person hours (WPH) for each step were 
calculated and all the steps were summed up to arrive at the 
WPH for each patient. Radiographers, medical physicists and 
radiation oncologists were given a weightage of 1, 2 and 3 
respectively for calculating the WPH. The data was analysed 
to see if experience reduces the time required. We also 
calculated the average WPH required for reducing the heart 
dose by 1 Gy. 
 
Results: The mean age was 51 years. 14 patients were known 
hypertensive on medications while none of them were known 
ischemic heart disease patients. Three were suffering from 
COPD. Twenty nine patients had breast conservation surgery 
while the remaining 21 patients underwent mastectomy. The 
mean WPH was 21.49 for the entire cohort. The average 
mean heart dose (MHD) in the free breathing (FB) technique 
was 380.96cGy and 160.61cGy in the DIBH technique (p 
=0.002). Average WPH required for the DIBH planning process 
was 13.09 and 8.39 for delivery. Patients were divided into 2 
cohorts, of 20 and 30 respectively, to assess if practice 
allowed reduction in DIBH WPH and this showed a decreasing 
trend of the WPH in the second cohort (22.2 vs 21.0, p=0.36). 
The average WPH required to reduce the MHD by 2.2 Gy was 
22.54 WPH. The average person hours of the oncologist 
required to reduce the MHD by 2.2 Gy was 0.39 hours, while 
that of medical physicists and radiographers were 2.89 and 
15.9 hours respectively.  
 
 
 
Conclusion: Although a resource intensive procedure, with 
practice the time required reduces with experience. On an 
average 10.25 WPH is required to reduce the MHD by 1 Gy, 
with 0.18 person hours of the oncologist versus 1.31 person 
hours of physicist and 7.23 person hours of radiographers 
time. 
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Purpose or Objective: Modern radiotherapy is able to 
provide highly precise and focused dose delivery with 
simultaneous target volume coverage and normal tissue 
avoidance. Proper selection and accurate definition of 
treatment volumes is of paramount importance. Anatom-e 
(Anatom-e Informations System Ltd, Houston, Tx) is a new 
platform able to drive, simplify, accelerate and standardize 
the contouring process in different oncological scenarios. 
Radiotherap-e is an online upgraded version providing the 
possibility to create an online network to share, discuss, 
control and optimize clinical cases, radiological images, 
radiotherapy contours and treatment approaches. We worked 
on the implementation of the aforementioned software in the 
Oncological Regional Network of Piedmont, Italy. 
 
Material and Methods: Four pilot centers within the 
Oncological Regional Network of Piedmont, Italy were 
connected with the online Radiotherap-e platform. 
Challenging clinical cases (head and neck, lung, esophageal 
and rectal cancers) were exchanged within the system 
(Figure 1). Treatment choices and volume delineation 
strategies were analyzed and compared before and after the 
use of the software.  
 
 
 
Results: The use of a unified distribution platform was able 
to eliminate compatibility issues based on different 
equipment or different treatment planning systems from site 
to site. Creation of consensus guidelines and common 
approaches took about 4 hours. Variation of treatment 
policies and contouring approaches due to platform use is 
under evaluation. 
 
Conclusion: The online software Radiotherap-e provided a 
common platform to share clinical, radiological and 
radiotherapic informations and allowed standardization and 
optimization of contouring strategies within a regional 
oncological network.  
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Purpose or Objective: To demonstrate the feasibility of a 
CBCT-based on-site simulation, planning, and delivery (OSPD) 
for whole brain radiotherapy, in which all steps from 
imaging, planning to treatment delivery are performed at the 
treatment unit in one appointment time slot. This work 
serves as the proof of concept for future OSPD single fraction 
radiation therapy. 
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Material and Methods: An integrated on-site imaging, 
planning and delivery workflow was developed and tested for 
whole brain radiotherapy. An automated two-opposed-
oblique-beam plan is created by utilizing the treatment 
planning system scripting and simple field-in-field IMRT. The 
IMRT plan is designed with maximum 8 control points to cover 
the target volume consisting of the brain to C1/C2 of the 
spinal cord, with dose homogeneity criteria from -5% to +7% 
of the prescription dose. Due to inaccuracy of reconstructed 
Hounsfield unit numbers in CBCT images, the dose 
distribution is calculated with non-heterogeneity correction 
introducing only clinically insignificant dose discrepancy. A 
coherent and synchronized workflow was designed for a team 
of attending physician, physicist, therapists, and dosimetrist 
to work closely with the ability to quickly modify, approve, 
and implement the treatment. 
 
 
 
Results: Thirty-one patients have been treated with this 
OSPD treatment, without compromising the plan quality 
compared to our regular clinically used parallel apposed 2D 
plans. The average time for these procedures are 48.02 
±11.55 minutes from the time patient entered the treatment 
room until s/he exited, and 35.09 ±10.35 minutes from 
starting CBCT until last beam delivered. This time duration is 
comparable to the net time when individual tasks are 
summed up during our regular CT-based whole brain planning 
and delivery. 
 
 
 
Conclusion: The OSPD whole brain treatment has been tested 
to be clinically feasible. The next step is to further improve 
the efficiency and to streamline the workflow. Other disease 
sites will be also tested with this new technology. 
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Purpose or Objective: For reasons of logistics in Italy, many 
public radiotherapy (RT) department deliver treatments to 
wide geographical areas. It is important that RT capacity is in 
the right place and that patients (pts) don't have to travel 
too far for their treatments. The aim of this study is to 
analyse the mobility for RT involving the RT Department of 
Ospedali Riuniti Marche Nord (AORMN) naturally devoted to 
satisfy RT needs of cancer pts living in Pesaro-Urbino (PU) 
province. 
 
Material and Methods: The Nomogramma di Gandy (NdiG) is 
a high-level tool which measures the degree to which an area 
or region is self-sufficient in the delivery of a specified public 
service. NdiG has been used to diagrammatic represent 
cancer pts flows for RT at AORMN. District and local datasets 
were used to obtain the number of local pts being treated by 
AORMN (Rr), the number of local pts irradiated by other RT 
Departments (E, “Exported” from an area), and the ones 
coming from outside that AORMN treated (I, “Imported” into 
an area). The three data enable to calculate two key 
indicators: X = The Percentage of Cancer pts Irradiated who 
were Residents = (Rr × 100) / (Rr + I) Y = The Percentage of 
Residents Irradiated Locally = (Rr × 100) / (Rr + E), useful to 
determine the Catchment Population for AORMN = Resident 
Population × (Y/X).  
 
Results: Between January and December 2013, 646 cancer 
pts living in PU district and 20 not resident pts were treated 
by AORMN, while 24 patients residing in PU area received RT 
by neighbouring RT centres. So during 2013, AORMN 
coordinates were as follows: X =96,99%, Y=96,42% and Y/X 
=0,99 (figure 1). Further analysing datasets, 35% of 
“Imported” pts received IMRT for Head and Neck cancers 
while the 67% of “Exported” pts underwent Stereotactic 
Radiation Therapy (SRT) not yet implemented at AORMN (50% 
stereotactic body radiation therapy and 17% stereotactic 
radiosurgery for brain metastasis). 
 
Conclusion: AORMN RT Service shows a great deal of self-
sufficiency, having values of both X and Y >90%. The degree 
to which people access their local RT services is important 
for planning and developing services themselves, thus the use 
of NdiG to compare access across many geographical areas or 
across many time periods could be a useful method for 
planning and commissioning RT centres at a local or regional 
level. The analysis of patients' flow pattern at AORMN 
suggests that the implementation of SRT could be useful to 
further reduce the number of PU users who should travel for 
RT. 
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Purpose or Objective: Only 5-10% of cancer patients eligible 
for randomized clinical trials (RCT) actually participate. The 
RAVES RCT (Trans-Tasman Radiation Oncology Group 08.03), 
compares adjuvant radiotherapy with early salvage 
radiotherapy for men with high risk features after 
prostatectomy. We aimed to determine attitudes and 
knowledge of potential participants regarding RAVES and 
RCTs, and examine decision-making preferences and 
decisional-conflict in men deciding on RAVES participation. 
